{"schema_version":"1","generated_at":"2026-11-02T21:27:04.762Z","data_as_of":null,"url":"https://www.findmykol.com/kol/hillary-maitland","json_url":"https://www.findmykol.com/kol/hillary-maitland/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"hillary-maitland","name":"Hillary Maitland","credential":"MD","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"institution":"University of Virginia","institution_url":"https://www.findmykol.com/institution/university-of-virginia","city":"Charlottesville","state":"VA","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1003075839","orcid":"0000-0002-9053-2048","openalex":"A5014192307"},"summary":"Hillary Maitland is a Hematology physician affiliated with University of Virginia. OpenAlex indexes 34 publications with 787 citations (h-index 13).","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"works_count":34,"cited_by_count":787,"h_index":13,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":24,"program_years":{"first":2021,"last":null},"rows_total":0,"shown":0,"withheld":0,"rows":[],"record_url":"https://openpaymentsdata.cms.gov/search?query=1003075839","source":"payments"},"prescribing":{"data_year":2023,"areas_total":3,"areas_shown":3,"areas":[{"area":"Blood & clotting","share_pct":77.4,"classes_total":1,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":77.4,"drugs":[{"name":"Eliquis","share_pct":72},{"name":"Xarelto","share_pct":28}],"max_beneficiaries":34}]},{"area":"Cancer & immunology","share_pct":17.3,"classes_total":2,"classes":[{"class":"Antimetabolite","setting":"prescribed","share_pct":12,"drugs":[{"name":"Hydroxyurea","share_pct":100}],"max_beneficiaries":null},{"class":"Complement Inhibitor","setting":"prescribed","share_pct":5.3,"drugs":[{"name":"Soliris","share_pct":100}],"max_beneficiaries":null}]},{"area":"Anti-infectives","share_pct":5.3,"classes_total":1,"classes":[{"class":"Penicillin-class Antibacterial","setting":"prescribed","share_pct":5.3,"drugs":[{"name":"Penicillin V Potassium","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2023,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":33,"shown":5,"withheld":28,"matched_by":"OpenAlex author record","recent":[{"title":"Real-world treatment patterns &amp; outcomes among patients with immune thrombocytopenia (ITP) who switched treatment from eltrombopag or romiplostim to avatrombopag in the United States: Results from the real-AVA 3.5 study","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-2683","status":"verified"},{"title":"Patient-centric care in primary immune thrombocytopenia (ITP): shared decision-making and assessment of health-related quality of life","year":2024,"journal":"Hematology","source_url":"https://doi.org/10.1080/16078454.2024.2375177","status":"verified"},{"title":"Risk‐based and individualised management of bleeding and thrombotic events in adults with primary immune thrombocytopenia (<scp>ITP</scp>)","year":2023,"journal":"European Journal Of Haematology","source_url":"https://doi.org/10.1111/ejh.14154","status":"verified"},{"title":"Avatrombopag treatment response in patients with immune thrombocytopenia: the REAL-AVA 1.0 study","year":2023,"journal":"Therapeutic Advances in Hematology","source_url":"https://doi.org/10.1177/20406207231179856","status":"verified"},{"title":"Recrudescent Heparin-Induced Thrombocytopenia After Therapeutic Plasma Exchange in a Patient Undergoing Thoracic Aortic Replacement","year":2023,"journal":"Journal of Cardiothoracic and Vascular Anesthesia","source_url":"https://doi.org/10.1053/j.jvca.2023.09.024","status":"verified"}],"source":"works"},"similar":[{"name":"Stephen Caldwell","slug":"stephen-caldwell","institution":"University of Virginia","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/stephen-caldwell","json_url":"https://www.findmykol.com/kol/stephen-caldwell/profile.json"},{"name":"Mark Deboer","slug":"mark-deboer","institution":"University of Virginia","specialty":"Pediatric Endocrinology","url":"https://www.findmykol.com/kol/mark-deboer","json_url":"https://www.findmykol.com/kol/mark-deboer/profile.json"},{"name":"Jaideep Kapur","slug":"jaideep-kapur","institution":"University of Virginia","specialty":"Neurological Surgery","url":"https://www.findmykol.com/kol/jaideep-kapur","json_url":"https://www.findmykol.com/kol/jaideep-kapur/profile.json"},{"name":"Mark Quigg","slug":"mark-quigg","institution":"University of Virginia","specialty":"Neurology","url":"https://www.findmykol.com/kol/mark-quigg","json_url":"https://www.findmykol.com/kol/mark-quigg/profile.json"},{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Jeffrey Miller","slug":"jeffrey-miller","institution":"University of Minnesota Medical School","specialty":"Hematology","url":"https://www.findmykol.com/kol/jeffrey-miller","json_url":"https://www.findmykol.com/kol/jeffrey-miller/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":28}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}